{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:08:17Z","timestamp":1793689697687,"version":"4.5.1"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fungal Genetics and Biology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.fgb.2019.103255","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T20:00:18Z","timestamp":1563566418000},"page":"103255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"special_numbering":"C","title":["Antifungal resistance in dermatophytes: Recent trends and therapeutic implications"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7020-7777","authenticated-orcid":false,"given":"Ananta","family":"Khurana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-3406","authenticated-orcid":false,"given":"Kabir","family":"Sardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-7462","authenticated-orcid":false,"given":"Anuradha","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fgb.2019.103255_b0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/1440-1681.12822","article-title":"Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children","volume":"44","author":"Allegra","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.fgb.2019.103255_b0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.183632","article-title":"Successful treatment of recurrent dermatophytosis with isotretinoin and itraconazole","volume":"82","author":"Ardeshna","year":"2016","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.fgb.2019.103255_b0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archderm.1981.01650010022016","article-title":"Griseofulvin-resistant dermatophytosis correlates with in vitro resistance","volume":"117","author":"Artis","year":"1981","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0020","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1439-0507.2008.01505.x","article-title":"Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient","volume":"51","author":"Balci","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103255_b0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003495-199243020-00010","article-title":"A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses","volume":"43","author":"Balfour","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.fgb.2019.103255_b0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11046-012-9571-6","article-title":"In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China","volume":"175","author":"Bao","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.fgb.2019.103255_b0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1574-6968.1991.tb04517.x","article-title":"Biochemical changes associated with the antifungal action of the triazole ICI 153,066 on Candida albicans and Trichophyton quinckeanum","volume":"79","author":"Barrett-Bee","year":"1991","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.fgb.2019.103255_b0040","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01291-18","article-title":"Overexpression or deletion of ergosterol biosynthesis genes alters doubling time, response to stress agents, and drug susceptibility in Saccharomyces cerevisiae","volume":"9","author":"Bhattacharya","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.fgb.2019.103255_b0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1473-3099(18)30079-3","article-title":"Emergence of recalcitrant dermatophytosis in India","volume":"18","author":"Bishnoi","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103255_b0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1439-0507.1998.tb00714.x","article-title":"Itraconazole in the treatment of tinea corporis and tinea cruris: comparison of two treatment schedules","volume":"41","author":"Boonk","year":"1998","journal-title":"Mycoses"},{"issue":"Suppl 2","key":"10.1016\/j.fgb.2019.103255_b0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1439-0507.1999.tb00024.x","article-title":"Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail","volume":"42","author":"Bradley","year":"1999","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103255_b0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1067\/mjd.2002.124699","article-title":"Dermatophytoma: Recalcitrance to treatment because of existence of fungal biofilm","volume":"47","author":"Burkhart","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000072449","article-title":"In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazolesusceptibility","volume":"49","author":"Carrillo-Mu\u00f1oz","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.fgb.2019.103255_b0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0190-9622(88)70037-7","article-title":"Pharmacokinetic profile of orally administered itraconazole in human skin","volume":"18","author":"Cauwenbergh","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/13693780500220449","article-title":"Molecular cloning and characterization of a novel ABC transporter gene in the human pathogen Trichophyton rubrum","volume":"44","author":"Cervelatti","year":"2006","journal-title":"Med. Mycol."},{"key":"10.1016\/j.fgb.2019.103255_b0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1439-0507.2004.01050.x","article-title":"In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan","volume":"47","author":"Chadeganipour","year":"2004","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103255_b0085","first-page":"e1000486","article-title":"Efflux in fungi: la pi\u00e8ce de r\u00e9sistance","volume":"5","author":"Coleman","year":"2009","journal-title":"PLoSPathog."},{"key":"10.1016\/j.fgb.2019.103255_b0090","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/08927014.2014.919282","article-title":"In vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms","volume":"30","author":"Costa-Orlandi","year":"2014","journal-title":"Biofouling"},{"key":"10.1016\/j.fgb.2019.103255_b0095","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/AAC.45.11.3162-3170.2001","article-title":"Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR","volume":"45","author":"Cruz","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0100","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.3390\/jof3020017","article-title":"Molecular identification and antifungal susceptibility patterns of clinical dermatophytes following CLSI and EUCAST guidelines","volume":"3","author":"Dabas","year":"2017","journal-title":"J. Fungi (Basel)"},{"key":"10.1016\/j.fgb.2019.103255_b0105","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1128\/AAC.00244-15","article-title":"Comparison of the in vitro activities of newer Triazoles and established antifungal agents against Trichophyton rubrum","volume":"59","author":"Deng","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2340\/00015555-2455","article-title":"Darier disease complicated by terbinafine-resistant Trichophyton rubrum: a case report","volume":"97","author":"Digby","year":"2017","journal-title":"Acta Derm. Venereol."},{"issue":"10\/3","key":"10.1016\/j.fgb.2019.103255_bib596","first-page":"225","article-title":"Antifungal drug susceptibility testing of dermatophytes: laboratory findings to clinical implications","volume":"May\u2013Jun","author":"Dogra","year":"2019","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.fgb.2019.103255_b0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archderm.1972.01620120032006","article-title":"Griseofulvin levels in stratum corneum. Study after oral administration in man","volume":"106","author":"Epstein","year":"1972","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00128071-200405060-00002","article-title":"Topical therapy for dermatophytoses: should corticosteroids be included?","volume":"5","author":"Erbagci","year":"2004","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0125","first-page":"161","article-title":"Clinical utility of in vitro antifungal susceptibility testing","volume":"13","author":"Espinel-Ingroff","year":"2000","journal-title":"Rev. Esp. Quimioter."},{"key":"10.1016\/j.fgb.2019.103255_b0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00632334","article-title":"In vitro susceptibility of Trichophyton rubrum isolates to griseofulvin and tioconazole. Induction and isolation of a resistant mutant to both antimycotic drugs. Mutant of Trichophyton rubrum resistant to griseofulvin and tioconazole","volume":"135","author":"Fachin","year":"1996","journal-title":"Mycopathologia"},{"issue":"Pt 8","key":"10.1016\/j.fgb.2019.103255_b0135","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1099\/jmm.0.46522-0","article-title":"Role of the ABC transporter TruMDR2 in terbinafine, 4- nitroquinoline N-oxide and ethidium bromide susceptibility in Trichophyton rubrum","volume":"55","author":"Fachin","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.fgb.2019.103255_b0140","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2340\/0001555571322326","article-title":"Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat","volume":"71","author":"Faergemann","year":"1991","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.fgb.2019.103255_b0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/000155557300304","article-title":"Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks","volume":"73","author":"Faergemann","year":"1993","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.fgb.2019.103255_b0150","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/AAC.40.2.443","article-title":"Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents","volume":"40","author":"Favre","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0155","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/mdr.2016.0095","article-title":"Mutations and\/or overexpressions of ERG4 and ERG11 genes in clinical azoles-resistant isolates of Candida albicans","volume":"23","author":"Feng","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.fgb.2019.103255_b0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.40.2.279","article-title":"Antifungal agents: chemotherapeutic targets and immunologic strategies","volume":"40","author":"Georgopapadakou","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0165","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1128\/JCM.42.7.2977-2979.2004","article-title":"Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes","volume":"7","author":"Ghannoum","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103255_b0170","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/AAC.38.9.2029","article-title":"Sterol composition of Cryptococcus neoformansin the presence and absence of fluconazole","volume":"38","author":"Ghannoum","year":"1994","journal-title":"Antimicrob. Agents Chemother,"},{"key":"10.1016\/j.fgb.2019.103255_b0175","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1128\/JCM.00818-06","article-title":"Voriconazole susceptibilities of dermatophyteisolates obtained from a worldwide tinea capitis clinical trial","volume":"44","author":"Ghannoum","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103255_b0180","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1128\/AAC.02382-13","article-title":"Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum","volume":"58","author":"Ghelardi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0185","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/13543780903176407","article-title":"New generation azole antifungals in clinical investigation","volume":"18","author":"Girmenia","year":"2009","journal-title":"Expert OpinInvestig. Drugs"},{"key":"10.1016\/j.fgb.2019.103255_b0190","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-4362.1994.tb01523.x","article-title":"In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore","volume":"33","author":"Goh","year":"1994","journal-title":"Int. J. Dermatol."},{"issue":"9","key":"10.1016\/j.fgb.2019.103255_b0195","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1128\/AAC.48.9.3530-3535.2004","article-title":"Terbinafine resistance mediated by salicylate 1-monooxygenase in Aspergillus nidulans","volume":"48","author":"Graminha","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0200","first-page":"166353","article-title":"Update in antifungal therapy of dermatophytosis","author":"Gupta","year":"2008","journal-title":"Mycopathologia"},{"key":"10.1016\/j.fgb.2019.103255_b0205","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2133.2003.05418.x","article-title":"In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity","volume":"149","author":"Gupta","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000074118","article-title":"Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy","volume":"207","author":"Gupta","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.fgb.2019.103255_b0215","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/1203475415574970","article-title":"The rise and fall of oral ketoconazole","volume":"19","author":"Gupta","year":"2015","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.fgb.2019.103255_b0220","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mjd.2001.110644","article-title":"Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis","volume":"44","author":"Gupta","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0225","first-page":"93","article-title":"Retention of ketoconazole in the skin following oral treatment","volume":"38","author":"Haneke","year":"1987","journal-title":"Hautarzt"},{"key":"10.1016\/j.fgb.2019.103255_b0230","series-title":"Rook\u2019s Textbook of Dermatology","first-page":"32.1","article-title":"Fungal infections","author":"Hay","year":"2016"},{"key":"10.1016\/j.fgb.2019.103255_b0235","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1042\/bst0211039","article-title":"Resistance of Candida albicansto azole antifungal agents","volume":"21","author":"Hitchcock","year":"1993","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"10.1016\/j.fgb.2019.103255_b0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/mmy.40.2.179.183","article-title":"In vitro susceptibility of Microsporumcanis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin","volume":"40","author":"Hofbauer","year":"2002","journal-title":"Med. Mycol."},{"key":"10.1016\/j.fgb.2019.103255_b0245","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1439-0507.1980.tb02628.x","article-title":"The influence of steroids on the antifungal and antibacterial activities of imidazole derivatives(author's transl)]","volume":"23","author":"H\u00f6gl","year":"1980","journal-title":"Mykosen"},{"key":"10.1016\/j.fgb.2019.103255_b0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11046-013-9655-y","article-title":"Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure","volume":"176","author":"Hryncewicz-Gw\u00f3\u017ad\u017a","year":"2013","journal-title":"Mycopathologia"},{"issue":"2","key":"10.1016\/j.fgb.2019.103255_b0255","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/jamadermatol.2014.2154","article-title":"Posaconazole treatment of extensive skin and nail dermatophytosis due to autosomal recessive deficiency of CARD9","volume":"151","author":"Jachiet","year":"2015","journal-title":"JAMA Dermatol."},{"issue":"4 Pt 2","key":"10.1016\/j.fgb.2019.103255_b0260","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0190-9622(90)70287-R","article-title":"Problems of resistant dermatophytes","volume":"23","author":"Jones","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0265","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11046-018-0242-0","article-title":"Resistance mechanism in a terbinafine-resistant strain of microsporumcanis","volume":"183","author":"Kano","year":"2018","journal-title":"Mycopathologia"},{"key":"10.1016\/j.fgb.2019.103255_b0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/mmy.39.1.109.116","article-title":"Identification and expression of multidrug resistancerelated ABC transporter genes in Candida krusei","volume":"39","author":"Katiyar","year":"2001","journal-title":"Med. Mycol."},{"key":"10.1016\/j.fgb.2019.103255_b0275","unstructured":"Khurana, A., Gupta, A., Sardana, K., 2019a. Patterns of use of topical steroids by patients with tinea corporis\/crurisand parameters determining development of atrophogenic effects (Unpublished results)."},{"key":"10.1016\/j.fgb.2019.103255_b0280","unstructured":"Khurana, A., Sardana, K., Gautam, R.K., Gupta, A., 2019b. An exploratory comparison of stratum corneum levels of systemic antifungal drugs with prevalent MIC levels: implications for drug dosimetry in dermatophytic infections of glabrous skin (unpublished results)."},{"key":"10.1016\/j.fgb.2019.103255_b0285","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01038-18","article-title":"Correlation of in vitro susceptibility based on MICs and squalene epoxidase mutations with clinical response to terbinafine in patients with Tinea Corporis\/Cruris","volume":"62","author":"Khurana","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.fgb.2019.103255_b0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/ijdvl.IJDVL_715_17","article-title":"Reinterpreting minimum inhibitory concentration (MIC) data of itraconazole versus terbinafine for dermatophytosis - time to look beyondthe MIC data?","volume":"84","author":"Khurana","year":"2018","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.fgb.2019.103255_b0295","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/myc.1990.33.3.136","article-title":"In vitro susceptibility of dermatophytes from Munich to griseofulvin, miconazole and ketoconazole","volume":"33","author":"Korting","year":"1990","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103255_b0300","doi-asserted-by":"crossref","first-page":"e01627","DOI":"10.1128\/AAC.01627-18","article-title":"Vitro and in vivo assessment of FK506 analogs as novel antifungal drug candidates","volume":"62","author":"Lee","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0305","first-page":"23","article-title":"Antifungal resistance: an emerging problem in Mexico","volume":"144","author":"Manzano-Gayosso","year":"2008","journal-title":"Gac Med. Mex."},{"key":"10.1016\/j.fgb.2019.103255_b0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1099\/jmm.0.002907-0","article-title":"Membrane transporter proteins are involved in Trichophyton rubrum pathogenesis","volume":"58","author":"Maranh\u00e3o","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.fgb.2019.103255_b0315","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11046-016-0057-9","article-title":"Pathogenesis of dermatophytosis: sensing the host tissue","volume":"182","author":"Martinez-Rossi","year":"2017","journal-title":"Mycopathologia"},{"key":"10.1016\/j.fgb.2019.103255_b0320","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3389\/fmicb.2018.01108","article-title":"Dermatophyte resistance to antifungal drugs: mechanisms and prospectus","volume":"9","author":"Martinez-Rossi","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.fgb.2019.103255_b0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1389202917666151116212437","article-title":"Heat shock proteins in dermatophytes: current advances and perspectives","volume":"17","author":"Martinez-Rossi","year":"2016","journal-title":"Curr. Genom."},{"key":"10.1016\/j.fgb.2019.103255_b0330","doi-asserted-by":"crossref","unstructured":"Martins, M.P., Franceschini, A.C.C., Jacob, T.R., et al., 2016. Compensatory expression of multidrug-resistance genes encoding ABC transporters in dermatophytes. 65, 605\u2013610. https:\/\/doi.org\/10.1099\/jmm.0.000268.","DOI":"10.1099\/jmm.0.000268"},{"key":"10.1016\/j.fgb.2019.103255_b0335","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1124\/mol.113.085902","article-title":"Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1","volume":"84","author":"Mast","year":"2013","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.fgb.2019.103255_b0340","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1468-3083.2006.01396.x","article-title":"What defines the quality of patient care in tinea pedis?","volume":"20","author":"Mistik","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.fgb.2019.103255_b0345","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.42.7.1695","article-title":"Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata","volume":"42","author":"Miyazaki","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0350","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/AAC.47.1.82-86.2003","article-title":"Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine","volume":"47","author":"Mukherjee","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0355","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/abbi.1993.1100","article-title":"The structural requirements of sterols for membrane function in Saccharomyces cerevisiae","volume":"300","author":"Nes","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.fgb.2019.103255_b0360","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-4362.1998.00541.x","article-title":"A comparison of the efficacy of oral fluconazole, 150 mg\/week versus 50 mg\/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis","volume":"37","author":"Nozickova","year":"1998","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0365","first-page":"140","article-title":"Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations","volume":"52","author":"Nyilasi","year":"2014","journal-title":"Med. Mycol."},{"key":"10.1016\/j.fgb.2019.103255_b0370","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1128\/AAC.47.11.3634-3636.2003","article-title":"In vitro analysis of the ability of Trichophyton rubrum to become resistant to terbinafine","volume":"47","author":"Osborne","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0375","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/13693780310001656803","article-title":"Antifungal drug response in an in vitro model of dermatophyte nail infection","volume":"42","author":"Osborne","year":"2004","journal-title":"Med. Mycol."},{"key":"10.1016\/j.fgb.2019.103255_b0380","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/AAC.49.7.2840-2844.2005","article-title":"Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine","volume":"49","author":"Osborne","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0385","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/AAC.01600-05","article-title":"Biological, biochemical, and molecular characterization of new clinical Trichophyton rubrum isolate resistant to terbinafine","volume":"50","author":"Osborne","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0390","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4103\/ijd.IJD_131_17","article-title":"Antifungal resistance in dermatology","volume":"63","author":"Pai","year":"2018","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0395","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1574-6968.2007.00710.x","article-title":"Analysis of Trichophyton rubrum gene expression in response to cytotoxic drugs","volume":"271","author":"Pai\u00e3o","year":"2007","journal-title":"FEMS Microbiol. Lett."},{"issue":"4","key":"10.1016\/j.fgb.2019.103255_b0400","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000246883","article-title":"Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and\/or tinea cruris","volume":"189","author":"Parent","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.fgb.2019.103255_b0405","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4103\/ijdvl.IJDVL_645_17","article-title":"A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India","volume":"84","author":"Pathania","year":"2018","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.fgb.2019.103255_b0410","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2180-10-39","article-title":"Transcriptional profiling reveals the expression of novel genes in response to various stimuli in the human dermatophyte Trichophyton rubrum","volume":"10","author":"Peres","year":"2010","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.fgb.2019.103255_b0415","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s40588-015-0015-1","article-title":"Update on antifungal drug resistance","volume":"2","author":"Perlin","year":"2015","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"10.1016\/j.fgb.2019.103255_b0420","first-page":"211","article-title":"Paradoxical response to itraconazole treatment in a patient with onychomycosis caused by Microsporumgypseum","volume":"75","author":"Pierard-Franchimont","year":"1995","journal-title":"Ann. Soc. Belg. Med. Trop."},{"key":"10.1016\/j.fgb.2019.103255_b0425","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2958.2003.03281.x","article-title":"Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene CnAFR1 involved in the resistanceto fluconazole","volume":"47","author":"Posteraro","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.fgb.2019.103255_b0430","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00352101","article-title":"Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals","volume":"27","author":"Prasad","year":"1995","journal-title":"Curr. Genet."},{"issue":"18","key":"10.1016\/j.fgb.2019.103255_b0435","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12895-018-0073-1","article-title":"Expert consensus on the management of dermatophytosis in India (ECTODERM India)","volume":"24","author":"Rajagopalan","year":"2018","journal-title":"BMC Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0440","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1073\/pnas.80.3.712","article-title":"Sterol synergism in yeast","volume":"80","author":"Ramgopal","year":"1983","journal-title":"Proc Natl Acad. Sci. USA"},{"key":"10.1016\/j.fgb.2019.103255_b0445","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0190-9622(82)70015-5","article-title":"Ketoconazole in griseofulvin-resistant dermatophytosis","volume":"6","author":"Robertson","year":"1982","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0450","doi-asserted-by":"crossref","first-page":"e02522","DOI":"10.1128\/AAC.02522-17","article-title":"Mutation in the squalene epoxidase gene of Trichophyton interdigitale and Trichophyton rubrum associated with Allylamine resistance","volume":"62","author":"Rudramurthy","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0455","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bst0180045","article-title":"Inhibition of squalene epoxidase and steroi side-chain methylation by allylamines","volume":"18","author":"Ryder","year":"1990","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.fgb.2019.103255_b0460","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/idoj.IDOJ_281_17","article-title":"Newer topical treatments in skin and nail dermatophyte infections","volume":"9","author":"Sahni","year":"2018","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.fgb.2019.103255_b0465","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10096-018-3317-4","article-title":"Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates","volume":"37","author":"Salehi","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103255_b0470","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1128\/AAC.43.11.2753","article-title":"The ATPbinding cassette transporter gene CgCDR1 from Candida glabratais involved in the resistance of clinical isolates to azole antifungal agents","volume":"43","author":"Sanglard","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0475","first-page":"378","article-title":"Terbinafine resistance conferred by multiple copies of the salicylate 1-monooxygenase gene in Trichophyton rubrum","volume":"56","author":"Santos","year":"2018","journal-title":"Med. Mycol."},{"issue":"6","key":"10.1016\/j.fgb.2019.103255_b0480","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4103\/ijd.IJD_435_17","article-title":"Rational for drug dosimetry and duration of terbinafine in the context of recalcitrant dermatophytosis: is 500 mg better than 250 mg OD or BD?","volume":"62","author":"Sardana","year":"2017","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0485","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/idoj.IDOJ_339_17","article-title":"Pilot analysis of morphometric assessment of itraconazole brands using dermoscopy and its relevance in the current scenario","volume":"9","author":"Sardana","year":"2018","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.fgb.2019.103255_b0490","series-title":"IADVL Manual on Management of Dermatophytoses","first-page":"80","article-title":"Overview of causes and treatment of recalcitrant dermatophytosis","author":"Sardana","year":"2018"},{"key":"10.1016\/j.fgb.2019.103255_b0495","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4103\/ijdvl.IJDVL_1012_16","article-title":"Intracutaneous pharmacokinetics of oral antifungals and their relevance in recalcitrant cutaneous dermatophytosis: Time to revisit basics","volume":"83","author":"Sardana","year":"2017","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.fgb.2019.103255_b0500","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/idoj.IDOJ_137_17","article-title":"Is antifungal resistance a cause for treatment failure in dermatophytosis: a study focused on Tinea Corporis and Cruris from a tertiary centre?","volume":"9","author":"Sardana","year":"2018","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.fgb.2019.103255_b0505","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/17512433.2019.1604218","article-title":"Parameters that determine dissolution and efficacy of itraconazole and its relevance to recalcitrant dermatophytoses","volume":"12","author":"Sardana","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.fgb.2019.103255_b0510","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.01185-06","article-title":"In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis","volume":"51","author":"Saunte","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0515","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/pde.13411","article-title":"Recurrent terbinafine resistant Trichophyton rubrum infection in a child with congenital ichthyosis","volume":"35","author":"Sch\u00f8sler","year":"2018","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0520","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/CMR.12.1.40","article-title":"Current and emerging azole antifungal agents","volume":"12","author":"Sheehan","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.fgb.2019.103255_b0525","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/myc.12772","article-title":"High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene","volume":"61","author":"Singh","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103255_b0530","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-03589-1","article-title":"A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes\/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: genomic insights and resistance profile","author":"Singh","year":"2019","journal-title":"Fungal Genetics Biol."},{"key":"10.1016\/j.fgb.2019.103255_b0535","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/0378-6323.194292","article-title":"Isotretinoin may affect pharmacokinetics of itraconazole in the skin: Is it rational to combine both for the treatment of dermatophytosis?","volume":"83","author":"Srivastava","year":"2017","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.fgb.2019.103255_b0540","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000017881","article-title":"Fluconazole in the treatment of tinea corporis and tinea cruris","volume":"196","author":"Stary","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.fgb.2019.103255_b0545","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2230.1992.tb00246.x","article-title":"Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis\/cruris and cutaneous candidiasis","volume":"17","author":"Suchil","year":"1992","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0550","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/AAC.37.10.2101","article-title":"Effects of itraconazole on cytochrome P-450-dependent sterol 14a-demethylation and reduction of 3-ketosteroids in Cryptococcus neoforinans","volume":"37","author":"VandenBossche","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0555","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/pai.12181","article-title":"Systemic treatment with isotretinoin suppresses itraconazole blood level in chronic granulomatous disease","volume":"25","author":"von Bernuth","year":"2014","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.fgb.2019.103255_b0560","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.fgb.2019.103255_b0565","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1439-0507.1994.tb00788.x","article-title":"Bioavailability of fluconazole in the skin after oral medication","volume":"37","author":"Wildfeuer","year":"1994","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103255_b0570","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12703\/P7-14","article-title":"Structure and mechanism of ABC transporters","volume":"7","author":"Wilkens","year":"2015","journal-title":"F1000Prime Rep."},{"issue":"4","key":"10.1016\/j.fgb.2019.103255_b0575","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/1567-1364.12042","article-title":"Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans","volume":"13","author":"Xiang","year":"2013","journal-title":"FEMS Yeast Res."},{"issue":"61","key":"10.1016\/j.fgb.2019.103255_b0580","first-page":"e00115","article-title":"Terbinafine resistance of trichophyton clinical isolates caused by specific point mutations in the squalene epoxidase gene","volume":"27","author":"Yamada","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103255_b0585","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/00015550310016571","article-title":"Deep dermatophytosis during topical tacrolimus therapy for psoriasis","volume":"83","author":"Yamamoto","year":"2003","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.fgb.2019.103255_b0590","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/ijd.12100","article-title":"In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey","volume":"52","author":"Yeni\u015fehirli","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.fgb.2019.103255_b0595","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/jam.14126","article-title":"Antifungal activity of immunosuppressants used alone or in combination with fluconazole","volume":"126","author":"Zhang","year":"2019","journal-title":"J. Appl. Microbiol."}],"container-title":["Fungal Genetics and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108718451930177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108718451930177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:44:35Z","timestamp":1761068675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108718451930177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":120,"alternative-id":["S108718451930177X"],"URL":"https:\/\/doi.org\/10.1016\/j.fgb.2019.103255","relation":{},"ISSN":["1087-1845"],"issn-type":[{"value":"1087-1845","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal resistance in dermatophytes: Recent trends and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Fungal Genetics and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fgb.2019.103255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103255"}}